$FLGT
Fulgent Genetics, Inc.

2018 Q4 Form 10-K Financial Statement

#000156459019008991 Filed on March 22, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $5.673M $5.625M $5.400M
YoY Change 32.52% 24.92% 16.38%
Cost Of Revenue $2.769M $2.612M $2.544M
YoY Change 8.8% 15.17% 35.39%
Gross Profit $2.904M $3.013M $2.856M
YoY Change 67.28% 34.81% 3.44%
Gross Profit Margin 51.19% 53.56% 52.89%
Selling, General & Admin $2.507M $2.421M $2.645M
YoY Change 1.01% -6.45% 32.85%
% of Gross Profit 86.33% 80.35% 92.61%
Research & Development $1.426M $1.438M $1.212M
YoY Change 7.7% 27.48% 31.74%
% of Gross Profit 49.1% 47.73% 42.44%
Depreciation & Amortization $600.0K $547.0K $562.0K
YoY Change 50.0% 24.89% 38.77%
% of Gross Profit 20.66% 18.15% 19.68%
Operating Expenses $3.933M $3.859M $3.857M
YoY Change 3.34% 3.85% 32.5%
Operating Profit -$1.029M -$846.0K -$1.001M
YoY Change -50.29% -42.88% 567.33%
Interest Expense $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$931.0K -$703.0K -$903.0K
YoY Change -52.81% -47.38% 2910.0%
Income Tax $888.0K -$318.0K -$100.0K
% Of Pretax Income
Net Earnings -$2.053M -$595.0K -$1.049M
YoY Change 26.42% -45.56% 4096.0%
Net Earnings / Revenue -36.19% -10.58% -19.43%
Basic Earnings Per Share -$0.11 -$0.03 -$0.06
Diluted Earnings Per Share -$0.11 -$0.03 -$0.06
COMMON SHARES
Basic Shares Outstanding 18.07M 18.01M 17.92M
Diluted Shares Outstanding 18.01M 17.92M

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.03M $32.60M $30.60M
YoY Change 17.18% 25.4% 5.88%
Cash & Equivalents $6.736M $8.489M $3.654M
Short-Term Investments $24.30M $24.11M $26.90M
Other Short-Term Assets $2.561M $2.370M $1.000M
YoY Change 5.05% 115.45% 11.11%
Inventory
Prepaid Expenses $556.0K $568.0K
Receivables $5.948M $6.077M $5.100M
Other Receivables $70.00K $1.600M $42.00K
Total Short-Term Assets $39.54M $41.05M $38.20M
YoY Change 20.09% 28.28% 10.09%
LONG-TERM ASSETS
Property, Plant & Equipment $6.446M $6.900M $7.300M
YoY Change -11.36% 6.15% 8.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.512M $1.746M $9.400M
YoY Change -21.94% -20.05% -9052.38%
Other Assets $17.00K $18.00K $600.0K
YoY Change -56.41% -82.0% 500.0%
Total Long-Term Assets $14.36M $13.75M $17.30M
YoY Change -40.8% -48.44% -28.23%
TOTAL ASSETS
Total Short-Term Assets $39.54M $41.05M $38.20M
Total Long-Term Assets $14.36M $13.75M $17.30M
Total Assets $53.90M $54.80M $55.50M
YoY Change -5.74% -6.6% -5.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.313M $1.000M $1.800M
YoY Change -37.15% -57.81% -1.1%
Accrued Expenses $1.259M $1.200M $1.200M
YoY Change 38.2% 53.65% 33.04%
Deferred Revenue $166.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.738M $2.300M $3.000M
YoY Change -8.73% -27.01% 7.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $14.00K $11.00K $0.00
YoY Change 133.33% 120.0%
Total Long-Term Liabilities $14.00K $11.00K $0.00
YoY Change 133.33% 120.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.738M $2.300M $3.000M
Total Long-Term Liabilities $14.00K $11.00K $0.00
Total Liabilities $2.752M $2.300M $3.000M
YoY Change -8.45% -32.33% -3.23%
SHAREHOLDERS EQUITY
Retained Earnings -$63.02M
YoY Change 9.28%
Common Stock $114.2M
YoY Change 2.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $51.15M $52.58M $52.56M
YoY Change
Total Liabilities & Shareholders Equity $53.90M $54.80M $55.50M
YoY Change -5.74% -6.6% -5.61%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$2.053M -$595.0K -$1.049M
YoY Change 26.42% -45.56% 4096.0%
Depreciation, Depletion And Amortization $600.0K $547.0K $562.0K
YoY Change 50.0% 24.89% 38.77%
Cash From Operating Activities $800.0K -$200.0K $0.00
YoY Change -161.54% -140.0% -100.0%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$1.000M -$100.0K
YoY Change -90.91% 233.33% -92.86%
Acquisitions
YoY Change
Other Investing Activities -$2.400M $6.000M -$1.500M
YoY Change 242.86% -360.87% -126.79%
Cash From Investing Activities -$2.500M $5.000M -$1.600M
YoY Change 47.06% -292.31% -138.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 800.0K -200.0K 0.000
Cash From Investing Activities -2.500M 5.000M -1.600M
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -1.700M 4.800M -1.600M
YoY Change -43.33% -328.57% -133.33%
FREE CASH FLOW
Cash From Operating Activities $800.0K -$200.0K $0.00
Capital Expenditures -$100.0K -$1.000M -$100.0K
Free Cash Flow $900.0K $800.0K $100.0K
YoY Change -550.0% 0.0% -95.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2438000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6736000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6490000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
24298000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
19994000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5948000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4005000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2561000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
39543000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
32927000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
6386000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
14883000
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1512000
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1937000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6446000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7272000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
126000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39000
CY2018Q4 us-gaap Assets
Assets
53904000
CY2017Q4 us-gaap Assets
Assets
57184000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1313000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2089000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1425000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
911000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2738000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3000000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Liabilities
Liabilities
2752000
CY2017Q4 us-gaap Liabilities
Liabilities
3006000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
51152000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
54178000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21351000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18730000
CY2017 us-gaap Operating Expenses
OperatingExpenses
13661000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53904000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57184000
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5538000
CY2018 us-gaap Operating Expenses
OperatingExpenses
15724000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114203000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
111884000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-44000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63018000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57664000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
590000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
287000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18172000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17847000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18172000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17847000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-5070000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-3482000
CY2018 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
434000
CY2017 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
481000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4636000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3001000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1015000
CY2018 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-4672000
CY2017 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1986000
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-935000
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-524000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-5607000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-2510000
CY2018 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.31
CY2017 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.14
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17978000
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-44000
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
81000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
53000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5598000
CY2018 us-gaap Cumulative Effect On Retained Earnings Before Tax1
CumulativeEffectOnRetainedEarningsBeforeTax1
327000
CY2018 us-gaap Cumulative Effect On Retained Earnings Tax1
CumulativeEffectOnRetainedEarningsTax1
74000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2304000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
2119000
CY2018 us-gaap Depreciation
Depreciation
2163000
CY2017 us-gaap Depreciation
Depreciation
1728000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1970000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-214000
CY2018 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-91000
CY2017 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1537000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
102000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17739000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
54479000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2119000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2304000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-363000
CY2017 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-124000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
533000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1098000
CY2017 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-675000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1331000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2322000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2895000
CY2017 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
3781000
CY2018 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-88000
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-5000
CY2018 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
297000
CY2017 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
370000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
309000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
160000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-336000
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-44000
CY2017 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
15000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24187000
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11659000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
27969000
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11185000
CY2018 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
510000
CY2017 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2461000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
950000
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
801000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-770000
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
81000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1407000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
757000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
85000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1014000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2049000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15000
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-44000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
246000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
6490000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
7897000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
6736000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments, assumptions and decisions that affect the reported amounts and related disclosures, including the selection of appropriate accounting policies and the assumptions on which to base accounting estimates. In making these estimates and assumptions and reaching these decisions, the Company applies judgment based on its understanding and analysis of the relevant circumstances, including historical data and experience available at the date of the accompanying consolidated financial statements, as well as various other factors management believes to be reasonable under the circumstances. Actual results could differ from these estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an on-going basis, management evaluates its estimates, primarily those related to: (i) revenue recognition criteria, (ii) accounts receivable and allowances for doubtful accounts, (iii) the useful lives of fixed assets, (iv) estimates of tax liabilities and (v) the valuation of equity-based awards.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk, Customers and Suppliers</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, accounts receivable and marketable securities, which consist of debt securities, and cash equivalents. As of December&#160;31, 2018, substantially all of the Company&#8217;s cash and cash equivalents were deposited in accounts at financial institutions, and amounts may exceed federally insured limits. Management believes that the Company is not exposed to significant credit risk due to the financial strength of the depository institutions in which its cash and cash equivalents are held.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain periods, a small number of customers has accounted for a significant portion of the Company&#8217;s revenue. Aggregating customers that are under common control or are affiliates, one customer comprised 13% of total revenue in the year ended December 31, 2018, and three customers comprised 14%, 12% and 10% of total revenue in the year ended December 31, 2017. One customer comprised 18% and 13% of total accounts receivable as of December 31, 2018 and 2017, respectively.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from the U.S. government was less than 10% of total revenue in each of the years ended December 31, 2018 and 2017.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company relies on a limited number of suppliers for certain laboratory substances used in the chemical reactions incorporated into its processes, referred to as reagents, as well as for the sequencers and various other equipment and materials it uses in its laboratory operations. In particular, the Company relies on a sole supplier for the next generation sequencers and associated reagents it uses to perform its genetic tests and as the sole provider of maintenance and repair services for these sequencers. The Company&#8217;s laboratory operations would be interrupted if it encounters delays or difficulties securing these reagents, sequencers, other equipment or materials or maintenance and repair services, which could occur for a variety of reasons, including if the Company needs a replacement or temporary substitute for any of its limited or sole suppliers and is not able to locate and make arrangements with an acceptable replacement or temporary substitute. The Company believes there are currently only a few other manufacturers that are capable of supplying and servicing some of the equipment and other materials necessary for its laboratory operations, including sequencers and various associated reagents.&nbsp;&nbsp;</p>
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
151000
CY2018 flgt Bad Debt Expense
BadDebtExpense
309000
CY2017 flgt Bad Debt Expense
BadDebtExpense
160000
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6000
CY2017 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
24000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2018 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ShippingAndHandlingMember
CY2018 flgt Federal And State Tax Expense Benefit Prior To Reorganization
FederalAndStateTaxExpenseBenefitPriorToReorganization
0
CY2018 us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
30776000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
104000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
30684000
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2692000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
35039000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
164000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
34877000
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
723000
CY2018 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
104000
CY2017 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
164000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2018Q4 flgt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2017Q4 flgt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
84000
CY2018 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2017 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12332000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5886000
CY2018Q4 flgt Reagents Current
ReagentsCurrent
314000
CY2017Q4 flgt Reagents Current
ReagentsCurrent
231000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
706000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
624000
CY2018Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1251000
CY2017Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1313000
CY2018Q4 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
220000
CY2017Q4 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
204000
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
70000
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
66000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
560000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
559000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
550000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
558000
CY2018Q4 flgt Operating Leases Future Minimum Payments Due After Four Years
OperatingLeasesFutureMinimumPaymentsDueAfterFourYears
1429000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3656000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
418000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
250000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
37000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
21000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2304000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2119000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 flgt Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit
22000
CY2018 flgt Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Unrepatriated Foreign Earnings
TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUnrepatriatedForeignEarnings
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-599000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-80000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-679000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-987000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-300000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-308000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-36000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1331000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0437
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0078
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0196
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0154
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0002
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0408
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0213
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2390
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0065
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3417
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
118000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
96000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
136000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
65000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
699000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
148000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
579000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
594000
CY2018Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
21000
CY2017Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
37000
CY2018Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
9000
CY2017Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
6000
CY2018Q4 flgt Deferred Tax Assets Foreign Taxes
DeferredTaxAssetsForeignTaxes
343000
CY2017Q4 flgt Deferred Tax Assets Foreign Taxes
DeferredTaxAssetsForeignTaxes
118000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
261000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2166000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1064000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1448000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
118000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
718000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
946000
CY2018Q4 flgt Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
644000
CY2017Q4 flgt Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
820000
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
74000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
718000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
820000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
126000
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17978000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17739000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17978000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17739000
CY2018 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.31
CY2017 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.14
CY2017Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1080000
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1383000
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
851000
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
891000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1379000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1306000
CY2018 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.31
CY2017 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.14
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
176000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
108000
CY2018Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2017Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5673000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5625000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5400000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4653000
CY2017Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4281000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4503000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4640000
CY2017Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5306000
CY2018Q4 us-gaap Cost Of Revenue
CostOfRevenue
2769000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
2612000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
2544000
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
2772000
CY2017Q4 us-gaap Cost Of Revenue
CostOfRevenue
2545000
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
2268000
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
1879000
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
1859000
CY2018Q4 us-gaap Gross Profit
GrossProfit
2904000
CY2018Q3 us-gaap Gross Profit
GrossProfit
3013000
CY2018Q2 us-gaap Gross Profit
GrossProfit
2856000
CY2018Q1 us-gaap Gross Profit
GrossProfit
1881000
CY2017Q4 us-gaap Gross Profit
GrossProfit
1736000
CY2017Q3 us-gaap Gross Profit
GrossProfit
2235000
CY2017Q2 us-gaap Gross Profit
GrossProfit
2761000
CY2017Q1 us-gaap Gross Profit
GrossProfit
3447000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1426000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1438000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1212000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1458000
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1324000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1128000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
920000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
851000
CY2018Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1128000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1115000
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1279000
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1130000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1366000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1487000
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1402000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1205000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1140000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1486000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
3933000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3859000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
3857000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
4075000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
3806000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
3716000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
2911000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
3228000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1029000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-846000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1001000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2194000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2070000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1481000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-150000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
219000
CY2018Q4 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
98000
CY2018Q3 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
143000
CY2018Q2 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
98000
CY2018Q1 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
95000
CY2017Q4 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
97000
CY2017Q3 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
145000
CY2017Q2 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
120000
CY2017Q1 flgt Interest And Other Income Expense
InterestAndOtherIncomeExpense
119000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-931000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-703000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-903000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2099000
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1973000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1336000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
338000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
888000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-318000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-434000
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-596000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-415000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-110000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106000
CY2018Q4 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1819000
CY2018Q3 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-385000
CY2018Q2 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-803000
CY2018Q1 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1665000
CY2017Q4 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1377000
CY2017Q3 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-921000
CY2017Q2 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
80000
CY2017Q1 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
232000
CY2018Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-234000
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-210000
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-246000
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-245000
CY2017Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-247000
CY2017Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-172000
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-105000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-2053000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-595000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1910000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1624000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-1093000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-25000
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11

Files In Submission

Name View Source Status
0001564590-19-008991-index-headers.html Edgar Link pending
0001564590-19-008991-index.html Edgar Link pending
0001564590-19-008991.txt Edgar Link pending
0001564590-19-008991-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
flgt-10k_20181231.htm Edgar Link pending
flgt-20181231.xml Edgar Link completed
flgt-20181231.xsd Edgar Link pending
flgt-20181231_cal.xml Edgar Link unprocessable
flgt-20181231_def.xml Edgar Link unprocessable
flgt-20181231_lab.xml Edgar Link unprocessable
flgt-20181231_pre.xml Edgar Link unprocessable
flgt-ex1023_11.htm Edgar Link pending
flgt-ex1024_270.htm Edgar Link pending
flgt-ex211_429.htm Edgar Link pending
flgt-ex231_265.htm Edgar Link pending
flgt-ex311_268.htm Edgar Link pending
flgt-ex312_267.htm Edgar Link pending
flgt-ex321_266.htm Edgar Link pending
g1pcrrv3sbjn000001.jpg Edgar Link pending
g1pcrrv3sbjn000002.jpg Edgar Link pending
ghndawbjqlde000001.jpg Edgar Link pending
ghndawbjqlde000002.jpg Edgar Link pending
gvsk3dn4oqxr000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending